|Titre :||Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance (Guidelines) (2011)|
|Auteurs :||T. KENDALL ; P. TYRER ; C. WHITTINGTON ; C. TAYLOR ; Guideline Development Group|
|Type de document :||Article : Périodique|
|Dans :||British Medical Journal (Vol.342, n°7800, 2 April 2011)|
|Article en page(s) :||760-762 ; d1351|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASETROUBLE BIPOLAIRE ; RECOMMANDATION ; PSYCHOSE ; PRISE EN CHARGE ; COMORBIDITE ; FACTEUR DE RISQUE ; ABUS ; DEPENDANCE
Many people with mental health problems use substances (including illicit drugs and alcohol), and for people with psychosis (predominantly schizophrenia and bipolar disorder), substance misuse occurs more frequently than in the general population. For example, a 1990 study in the United States reported a 47% lifetime prevalence rate of substance misuse among people with schizophrenia and 60% among people with bipolar disorder; in the general population, the substance misuse rate was 16%.
People with psychosis commonly take various non-prescribed substances to cope with their symptoms, and in about a third of people with psychosis, this amounts to hazardous, harmful, or dependent use. Among people with psychosis, those with coexisting substance misuse have a higher risk of relapse and admission to hospital, higher mortality, and higher levels of unmet needs. This is partly because the substances used may exacerbate the psychosis or interfere with pharmacological or psychological treatment.
This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the assessment and management of psychosis and coexisting substance misuse in adults and young people.
|Domaine :||Plusieurs produits / Several products|
|Refs biblio. :||15|
|Affiliation :||1National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London E1 8AA, United Kingdom / Royaume-Uni|